Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrin-physiological and pathophysiological role: clinical consequences

H L Waldum1, E Brenna, P M Kleveland

  • 1Institute of Cancer Research, University Hospital, Trondheim, Norway.

Digestive Diseases (Basel, Switzerland)
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: proton pump inhibitors (PPIs) and primary liver cancer.

Alimentary pharmacology & therapeutics·2018
Same author

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.

Journal of internal medicine·2018
Same author

Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.

Alimentary pharmacology & therapeutics·2015
Same author

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis.

Blood cancer journal·2015
Same author

The regulation of gastric acid secretion - clinical perspectives.

Acta physiologica (Oxford, England)·2013
Same author

Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.

Clinical and experimental immunology·2013

Gastrin regulates stomach acid by stimulating histamine release from ECL cells. Long-term high gastrin levels may increase cancer risk, while low levels could also contribute to gastric stump carcinoma.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Oncology

Background:

  • Gastrin is a key regulator of gastric acid secretion.
  • Meal intake stimulates gastrin release, explaining meal-stimulated acid secretion.
  • Gastrin primarily acts via histamine release from enterochromaffin-like (ECL) cells.

Purpose of the Study:

  • To investigate the role of gastrin in acid secretion and gastric cell growth.
  • To explore the potential link between gastrin levels and gastric carcinogenesis.
  • To examine the direct effects of gastrin on parietal cells.

Main Methods:

  • The study reviews the physiological roles of gastrin.
  • It discusses the impact of gastrin on ECL cell function and growth.
  • It considers the implications of hypergastrinemia and hypogastrinemia in gastric pathology.

Related Experiment Videos

Main Results:

  • Gastrin stimulates acid secretion through ECL cells and promotes ECL cell growth.
  • Long-term hypergastrinemia may lead to ECL cell carcinoids.
  • The role of ECL cells in gastric cancer is debated, but avoiding prolonged iatrogenic hypergastrinemia is advised.

Conclusions:

  • Gastrin's influence extends to gastric cell growth, with potential carcinogenic implications.
  • Hypogastrinemia might also be a risk factor for gastric stump carcinoma.
  • Further research is needed to clarify gastrin's direct effects on parietal cells and its precise role in gastric cancer.